Skip to main content

Royan Ajay's Form 4 filing

Fractyl Health, Inc.GUTS · filed Feb 8, 2024

Accession no.
0000950170-24-012838
Filed
Feb 8, 2024
Trade date
Feb 6, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 5 derivative transactions. Open-market purchases total $5.00M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Royan AjayCIK 0001875614Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 6, 2024Common StockCConversionAcquired+5,160,301–F1–5,160,301Indirect
Feb 6, 2024Common StockCConversionAcquired+918,567–F1–918,567Indirect
Feb 6, 2024Common StockPPurchaseAcquired+333,333$15.00+$4,999,9951,251,900Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 6, 2024Common StockCConversionDisposed−1,875,938–F1–0Indirect
Feb 6, 2024Common StockCConversionDisposed−3,030,193–F1–0Indirect
Feb 6, 2024Common StockCConversionDisposed−254,170–F1–0Indirect
Feb 6, 2024Common StockCConversionDisposed−173,821–F1–0Indirect
Feb 6, 2024Common StockCConversionDisposed−744,746–F1–0Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

In connection with the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into 0.466 shares of the Issuer's common stock in accordance with the terms of such preferred stock.

Referenced by the price of 2 transactions in Table I and 5 transactions in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)